Your Location:
Home >
Browse articles >
Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study
RESEARCH | Updated:2026-06-10
    • Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study

    • Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study

    • Military Medical Research   2026年13卷第5期 页码:689-705
    • DOI:10.1186/s40779-025-00659-3    

      中图分类号:
    • 收稿:2025-01-10

      录用:2025-10-02

      网络首发:2025-10-15

      纸质出版:2026-05

    Scan QR Code

  • Chao Zheng, Guo-Chao Zhang, Long Zhang, 等. Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study[J]. Military Medical Research, 2026,13(5):689-705. DOI: 10.1186/s40779-025-00659-3.

    Chao Zheng, Guo-Chao Zhang, Long Zhang, et al. Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study[J]. Military Medical Research, 2026, 13(5): 689-705. DOI: 10.1186/s40779-025-00659-3.

  •  
  •  

0

浏览量

6

Downloads

0

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Exosome autoantibody biomarkers for detection of lung cancer
China stroke surveillance report 2021
Establishment and effectiveness evaluation of a scoring system for exertional heat stroke by retrospective analysis
Relationship between expression of cathepsin D and proliferating cell nuclear antigen and prognosis in osteosarcoma
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer

相关作者

Nurul Huda Rutt
Win Lwin Thuya
Janique Michelle Peyper
Tan Ti Myen
Nur Diana Anuar
Arif Anwar
Boon Cher Goh
Ling-Zhi Wang

相关机构

Department of Haematology-Oncology, National University Cancer Institute, National 17 University Health System
Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 15 1E Kent Ridge Road
NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore
Cancer Science Institute of Singapore, National University of Singapore
0